No products in the cart.
Marketed By: Sanofi Aventis
Therapeutic Segment: Long Acting Insulin
Generic: Insulin glargine
Indication:
Toujeo® (Insulin Glargine U300) is the next-generation insulin glargine which works like the human body's natural insulin and is designed to provide steady control over 24 hours. Toujeo® provides stable glycemic control over 24 hours and provides dosing flexibility with less risk of hypoglycemia.
Product Form: Pen
Storage Condition: Store at 2 – 8°C (Do not freeze)
Pack Size: 1.5mlx3's
Weight | 250 g |
---|---|
Dimensions | 10 × 10 × 10 cm |
Click one of our contacts below to chat on WhatsApp